Pfizer's sales missed estimates for the quarter as the drugmaker tries to transition out of the pandemic. Pfizer chairman and CEO Albert Bourla discusses the path ahead for the company, including its plans for acquisitions. He speaks with Bloomberg Wall Street Week host David Westin. See omnystudio.com/listener for pri

Albert Bourla is the Chairman and CEO of Pfizer. Please support this podcast by checking out our sponsors: - Notion: https://notion.com/startups to get up to $1000 off team plan - Calm: https://calm.com/lex to get 40% off - Hunter Douglas: https://www.hunterdouglas.com/lex to get a free design guide - LMNT: https://dri

COVID-19 took over the world over the past 16 months, causing death and disruption in country after country. But there’s hope now - because of the rapid development of COVID-19 vaccines. Pfizer CEO Albert Bourla joins LinkedIn Editor-in-Chief Daniel Roth to discuss how Pfizer and BioNTech raced against time and convent

Pfizer on Monday announced that its COVID-19 vaccine has proven effective in preventing infection in over 90% of Phase 3 clinical trial patients, and added that it could have 50 million doses available by year-end. Dan talks to Pfizer CEO Albert Bourla about data, distribution, politics, and how he reacted upon receivi